from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1630/rpsA

LFCtreatmentdescriptionclass of inhibitor

-0.351

Amikacinug/mL Amikacintranslation

-0.051

Cap5-10ug/mL Capreomycintranslation

0.422

Rox10-50 ug/mL Roxithromycintranslation

1.509

SM2-5 ug/mL Streptomycintranslation

0.074

Tet5-10 ug/mL Tetracyclinetranslation

-0.691

Rif0.2-5ug/mL Rifampicintranscription

-0.402

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.128

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.255

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.905

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.435

Clofazimine10-13 ug/mL Clofaziminerespiration

0.340

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.103

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.792

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.445

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.311

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.403

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.593

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.266

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.042

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.166

KCN5-20 ug/mL Potassium cyaniderespiration

-0.208

NaN30.2-2 mM Sodium aziderespiration

1.939

Nigericin50 uM Nigericinrespiration

-0.959

TRC10-150 ug/mL Triclosanrespiration

-1.975

TRZ10-25 ug/mL Thioridazinerespiration

0.128

Valinomycin0.5-10 uM Valinomycinrespiration

1.050

ZnSO42 mM ZnSO4respiration

-0.048

menadione6-10 ug/mL Menadionerespiration

-0.159

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.440

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.037

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.992

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.917

NRP_1Non-replicating persistence stage 1dosRassociated

1.218

Amp0.2mg/mL AmpicillincellWall

0.435

Cephalexin20-100 ug/mL CephalexincellWall

0.841

Cerulenin0.32-5 ug/mL CerulenincellWall

0.692

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.511

EMB10-20 ug/mL EthambutolcellWall

0.328

Eta12-40 ug/mL EthionamidecellWall

0.219

INH0.2-0.4 ug/mL IsoniazidcellWall

0.618

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.157

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.686

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.029

BZA0.12 mg/mL BenzamidearomaticAmides

-0.030

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.423

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.766

H2O24 mM hydrogen peroxideDNAdamaging

1.042

Levo10 ug/mL LevofloxacinDNAdamaging

1.115

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.079

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.115

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.360

UVUV-irradiationDNAdamaging

-1.363

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.087

Antimycin12.5-50 ug/mL Antimycin A?

0.711

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.351

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.344

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.174

PA8240.2-2 ug/mL PA-824?

-0.502

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.281

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.089

Verapamil50 uM Verapamil?

0.768

mercaptoethanol2 mM 2-Mercaptoethanol?

0.372

methoxatin10-20 ug/mL Methoxatin?